Ramucirumab (Cyramza) - Oncology Nurse Advisor

Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide

This slideshow reviews ramucirumab (Cyramza), indicated for advanced gastric or gastro-esophageal junction (GEJ) adenocarcinoma.

Topics:

Drug Information Gastric Cancer Gastrointestinal Cancer Slideshows Stat Consult

Next hm-slideshow in Slides

Erlotinib (Tarceva)